Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05659394 · ClinicalTrials.gov registry record · NA

Intermittent Pneumatic Compression of the Thigh

A NA study of Venous Leg Ulcer, sponsored by Huntleigh Healthcare.

Completed
Registry status
NA
Development phase
136
Enrollment target
5
Study locations

NCT05659394: Completed NA study of Venous Leg Ulcer, sponsored by Huntleigh Healthcare.

NCT05659394 is a NA study of Venous Leg Ulcer that has completed, run by Huntleigh Healthcare. The registered enrollment target is 136 participants, below the 241-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (44% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05659394, a NA study of Venous Leg Ulcer, has completed, sponsored by Huntleigh Healthcare.

COMPLETED
Registry status
NA
Development phase
136 participants
Enrollment target
5
Study locations

Study Summary

Study Summary A leg ulcer is a long-lasting (chronic) sore that takes more than two weeks to heal. The majority of leg ulcers are caused either by problems with the veins in the legs; these are called 'venous leg ulcers' (VLU), or a combination of both venous and arterial disease which affects the veins and arteries in the leg; these are called 'mixed aetiology ulcers'(MLU). Venous and mixed aetiology leg ulcers are usually treated by applying a simple non-stick dressing to the ulcer with a firm compression bandage applied on top. These bandages are designed to squeeze the legs and encourage blood flow towards the heart. Before this treatment starts, a patient may undergo tests to check the flow of blood in the leg arteries is adequate. This ensures that compression bandaging can be safely applied to assist wound healing without compromising arterial blood flow. Most venous and mixed aetiology leg ulcers heal within three to four months if they're treated by a healthcare professional trained in compression therapy for leg ulcers. However, some ulcers can be more problematic and may persist for many months or even years despite being treated with the gold standard treatment of compression bandages. We therefore need to find more ways of helping these problematic ulcers to heal. Intermittent Pneumatic Compression (or IPC) is another way of compressing legs to try and improve the circulation. IPC consists of a sleeve or garment which is applied to the leg. The sleeve is connected to a pump which gently inflates and then deflates it to squeeze the leg in a massage like manner. The IPCOTT study aims to find out if a new IPC device, known as the WoundExpress can help to heal leg ulcers. The WoundExpress has a sleeve that patients put around the thigh, like the one applied to the arm when people have their blood pressure taken. Users need to be either sitting with their legs raised or lying down when using the device. Pressing the 'start' button on the pump causes the

Primary Outcome

Assess percentage change to wound surface area of the reference ulcer following a 16-week intervention period as assessed by the percentage of change in wound surface. This will be calculated using the measurements from wound photographs and by dividing the change by the baseline area. A percentage below zero will indicate an increase in wound size and a percentage above zero indicates a reduction in wound size at week 16 compared with baseline.

Conditions Studied

Interventions

  • OTHER Standard Wound Care Alone
  • DEVICE Stand Wound Care plus IPC

Study Locations (5)

Florida

  • Royal Research - Hollywood
  • Three Rivers Wound and Hyperberic - North Port

Oklahoma

  • Wound Care of Tulsa - Tulsa

Pennsylvania

  • SerenaGroup - Monroeville

Texas

  • SerenaGroup Research - Austin

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2023-01-25
Est. Completion 2024-03-31
Phase NA
Huntleigh Healthcare

2 total trials

What the finished NCT05659394 record still lists

NCT05659394 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, below the 241-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (44% lower).

The record links to 1 condition, with Venous Leg Ulcer appearing as the primary indexed condition, and to 2 interventions - of which Standard Wound Care Alone is the first listed.

NCT05659394 lists 5 locations in 4 states (Florida, Oklahoma, Pennsylvania).

Frequently Asked Questions

What is clinical trial NCT05659394 about?

NCT05659394 is a clinical study titled "Intermittent Pneumatic Compression of the Thigh". Study Summary A leg ulcer is a long-lasting (chronic) sore that takes more than two weeks to heal. The majority of leg ulcers are caused either by problems with the veins in the legs; these are called 'venous leg ulcers' (VLU), or a combination of both venous and arterial disease which affects the ...

What is the current status of trial NCT05659394?

This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2023-01-25. Estimated completion is 2024-03-31.

What conditions does trial NCT05659394 study?

This clinical trial studies the following conditions: Venous Leg Ulcer.

What interventions are being tested in trial NCT05659394?

The interventions under investigation include: Standard Wound Care Alone (OTHER), Stand Wound Care plus IPC (DEVICE).

Who is sponsoring clinical trial NCT05659394?

This trial is sponsored by Huntleigh Healthcare, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05659394 being conducted?

This trial has 5 study locations across Florida, Oklahoma, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Venous Leg Ulcer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05659394's enrollment target sits among peer trials

136 19th of 35 higher than 16 of 35 other Venous Leg Ulcer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Venous Leg Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01555892 · 136 participants · Phase 1

    Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

  • NCT03216525 · 136 participants · Phase 3

    Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

  • NCT04476901 · 136 participants · Phase 2

    Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy

  • NCT04603898 · 136 participants · NA

    Oxalate Formation From Ascorbic Acid

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05659394, the US trial registry maintained by the National Library of Medicine. NCT05659394 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.